• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    E

    Emory and Henry College

    院校EST. 1836
    563论文总数
    6,087引用总数

    Emory & Henry College (E&H or Emory) is a private liberal arts college in Emory, Virginia. The campus comprises 335 acres (1.36 km2) of Washington County, which is part of the Appalachian highlands of Southwest Virginia. Founded in 1836, Emory & Henry College is the oldest institution of higher learning in Southwest Virginia.

    论文量&引用量时间轴

    机构学者

    论文(563)

    年份
    起
    –
    止
    排序
    1WITHDRAWN: Geographic Variation in Pregnancy-Associated Overdose and Substance Use Disorder Mortality, 2016-2022.
    Michael R Kramer, Emily Peterson,Hannah Cooper

    The authors have withdrawn this manuscript because of statistical software coding errors discovered after submission in the approach used to aggregate overdose deaths. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

    2026medRxiv the preprint server for health sciences(2026)
    引用
    AI阅读
    加入学术空间
    2A Residual-Ratio Framework for Auditing Transcriptomic Gene Signatures Against Background Expression Structure
    Ying Zhu, Chenyu Zhang,Vince D Calhoun, Yuda Bi

    Background: Transcriptomic gene signatures are widely used to infer pathway activity and biological mechanism from bulk cancer expression data, yet current evaluation strategies primarily emphasize internal coherence, predictive performance, or scoring robustness. A quantitative framework for assessing how much signature variation remains independent of background expression structure has been lacking. Results: Unlike existing single-number signature-quality metrics such as Berglund uniqueness, residual-ratio auditing reports a trajectory across null-model richness: for each signature we compute the residual ratio resratio(k) = 1 - sum_{j=1}^{k}(mathbf{q}_j^top mathbf{h})^2 at progressively enriched expression-PC subspaces, together with an inverse-participation-ratio (IPR) concentration diagnostic that reports the effective number of axes absorbing each signature. Applied to a curated 17-entry benchmark, all 50 MSigDB Hallmark gene sets, and 1181 Reactome pathways across 8 TCGA cancer types (4462 samples), with external validation in METABRIC, the framework produces two complementary readouts. First, the curated panel is absorbed into the ExprPC50 subspace at residual ratios 18--43% below size-matched random 30-gene baselines in every cancer (curated mean resratio range 0.109--0.177 vs. random mean 0.18--0.288), providing the framework's central quantitative discrimination between biologically coherent signatures and arbitrary gene combinations. Second, within the curated panel the ExprPC50 residual ratio is negatively correlated with the top-5 absorption concentration in every cancer (Spearman rho from -0.59 in PRAD to -0.89 in SKCM, median -0.71; all 8 significant at p < 0.05, most at p < 10^-3); we report this correlation as a descriptive geometric property of the null-model coordinate system rather than as a biological law, because 1000 random 30-gene draws projected through the same top-50 expression-PC basis reproduce the same pan-cancer median rho (-0.73; Supplementary Table~ref{tab:S17}), and it is robust to compositional nuisance: after rebuilding the null basis as immune-PC1 oplus stromal-PC1 oplus proliferation-PC1 plus 47 residual PCs, the per-cancer rho becomes more negative rather than shallower (median -0.86; Supplementary Table~ref{tab:S18}), ruling out tumor purity, immune infiltrate, and stromal fraction as drivers of the pattern. Because absorption at ExprPC50 is a geometric property of how any signature direction sits in expression-PC space, tier-level distributional structure at this operating point is not separable beyond the low-vs-upper band split: a Kruskal--Wallis omnibus is significant (p = 4.9 x 10^-13), but pairwise Dunn's post-hoc tests show that Tiers~1, 4, and~5 are not separable (p_{\mathrm{BH}} > 0.2). The trajectory shape itself is empirically bootstrap-invariant: across 200 sample-level fixed-basis bootstrap resamples of the 17 curated entries in BRCA, the mean pairwise Pearson correlation of trajectory-shape vectors is 0.999, and individual cell-level 95% bootstrap CI half-widths at B = 1000 resamples are in the range 0.002--0.053. External replication in the METABRIC breast cancer cohort (n_{\text{samples}} = 1980, microarray) showed moderate-to-strong rank-ordering concordance with TCGA-BRCA across the 17 curated entries (Spearman rho = 0.72 on the 17-signature ordering, 95% Fisher-z CI 0.37--0.89, p = 0.001). Under an upper-bound sensitivity analysis, 45 of 50 Hallmark gene sets and 992 of 1181 Reactome pathways had ExprPC200 residual ratios below the mean of their size-matched random baselines---a descriptive statistic reflecting axis alignment under rich null models, not a failure rate. In causal DAG simulations (n_{mathrm{rep}} = 100 replicates), a signature driven entirely by a latent confounder retained resratio = 0.233 at ExprPC50, numerically comparable to Tier~1 validated drivers, so a single-point residual ratio cannot adjudicate confounder-independence. The framework's load-bearing signals are therefore the trajectory shape (statistically invariant under sample-level resampling) and the magnitude gap between the curated panel and its random 30-gene baseline (the curated-vs-random discrimination), read jointly---not the value of resratio at any single null-model dimensionality. Conclusions: Residual-ratio auditing provides an interpretable and practical framework for quantifying how much of a transcriptomic gene signature's variance remains orthogonal to a chosen background-expression model. The two statistically reliable quantities it reports are (i) the shape of the trajectory resratio(k) across null-model richness, which is bootstrap-invariant across sample-level resamples, and (ii) the magnitude gap between the curated panel's residual ratio and size-matched random 30-gene baselines at a fixed operating point, which is 18-43% in all 8 TCGA cancers and survives a purity-aware null-model construction. The negative correlation between resratio and the top-5 absorption concentration $c$ (curated-panel median rho = -0.71) is reproduced by random 30-gene sets under the same basis (random-draw median rho = -0.73) and is therefore best read as a descriptive geometric property of the null-model coordinate system rather than a biological discovery about curated signatures. Any single operating-point residual ratio carries materially wider cell-level uncertainty than the trajectory shape and cannot, on its own, adjudicate confounder-independence. The framework's outputs describe a signature's geometric relationship to modeled background expression structure and do not evaluate clinical utility: a signature with a low residual ratio may still be clinically valuable when that low value reflects alignment with a strong prognostic or actionable program such as proliferation, immune infiltration, or cell cycle, and the framework is not a substitute for calibrated prognostic or predictive classifiers. All findings are based on bulk RNA-seq (TCGA PanCancer Atlas, 8~cancer types) and microarray (METABRIC) data; transfer to single-cell, single-nucleus, or spatial transcriptomics is out of scope and not claimed. Used within this scope---reading the trajectory shape and the magnitude-gap signal jointly, rather than the value of resratio at any one k---the framework adds a complementary audit layer to existing pathway-scoring and experimental-validation workflows, and supports more calibrated interpretation, comparison, and reporting of transcriptomic gene signatures in cancer studies.

    2026
    引用
    AI阅读
    加入学术空间
    3Multiple Sources of Β2*-Nicotinic Acetylcholine Receptor Binding Are Differentially Affected During Tobacco Smoking Abstinence As Revealed by Independent Component Analysis of [18f]flubatine PET Images
    Nakul R. Raval,Katina C. Calakos,Ming-Qiang Zheng,Anita Huttner,Irina Esterlis,Henry Huang, Vince D. Calhoun, Marina R. Picciotto, Kelly P. Cosgrove, Ansel T. Hillmer

    Tobacco smoking, a major cause of preventable mortality, upregulates β2 subunit-containing nicotinic acetylcholine receptors (β2*-nAChR) in most brain regions. Although the α4 subunit most frequently co-assembles with β2, other subunits likely assemble with β2 and contribute to distinct aspects of nicotine-mediated behaviors, but these factors are poorly understood in people. This work performed independent component analysis (ICA) of [18F]Flubatine positron emission tomography (PET) image data to identify maximally independent sources of specific binding to β2*-nAChRs. We then compared their magnitudes (loading coefficients) in people who recently stopped smoking cigarettes (abstinent smokers; n = 26) and people who never smoked cigarettes (non-smokers; n = 20). ICA identified 3 reproducible components: IC1 (36% of variance) in medial thalamus, lateral thalamus, and red nucleus; IC2 (18% of variance) in ventral thalamus, lateral geniculate, and midbrain; IC3 (19% of variance) in cerebellum and optic circuitry in midbrain. Nicotine challenge in an independent sample (n = 9) reduced loading coefficients of all components, confirming specific binding to nAChRs. Post-mortem autoradiography of cerebellum showed greatest [18F]Flubatine displacement by α3/α6β2*-nAChR blocker (α-Conotoxin MII) but low displacement by α6β2*-nAChR blocker (α-Conotoxin PIA), suggesting that IC3 measures α3β2*-nAChRs specific binding – a novel finding in living people. Loading coefficients of IC1 and IC2 were significantly lower in abstinent smokers compared to non-smokers. IC3 loading coefficients were significantly higher during extended smoking abstinence, and exploratory analyses suggested initial evidence for daily smoking amount correlating with nicotine dependence severity. These results could inform novel treatment development to help people quit smoking.

    2026Neuropsychopharmacology(2026)
    引用
    AI阅读
    加入学术空间
    4Microstructural Disruption of the Forceps Minor in Schizophrenia: A Potential Clinical Imaging Biomarker Using Translational DTI
    Qiang Li, Godfrey D Pearlson,Vince D Calhoun

    Schizophrenia is one of the most complex brain disorders, arising from multidimensional pathophysiological processes that span genetic vulnerability, neurotransmitter dysregulation, structural brain damage, and large-scale brain network dysfunction. Large-scale neuroimaging studies have consistently demonstrated the critical role of frontal brain regions in schizophrenia. Despite substantial progress, the precise localization of structural damage within these regions and the neurobiological mechanisms linking such alterations to disease pathology remain poorly understood. In this study, we included a total of 115 subjects from two sites of the B-SNIP dataset, comprising 60 healthy controls and 55 individuals with schizophrenia. We employed diffusion tensor imaging (DTI) to precisely characterize specific structural alterations in the frontal brain regions associated with schizophrenia. Our findings reveal significant microstructural abnormalities in the forceps minor, a major commissural white-matter tract that serves as a critical interhemispheric bridge between the bilateral frontal lobes. Network-level mapping further demonstrates that the forceps minor is closely integrated with large-scale brain networks, particularly the default mode network, and maintains strong structural connectivity with orbitofrontal regions-both of which are known to exhibit dysfunction in schizophrenia. Moreover, converging evidence suggests that the forceps minor plays an important role in the regulation of social behavior, a core domain of impairment in schizophrenia. Collectively, these findings identify the forceps minor as a promising structural imaging biomarker for schizophrenia and provide novel insights into the microstructural mechanisms underlying the disorder.

    2026bioRxiv the preprint server for biology(2026)
    引用
    AI阅读
    加入学术空间
    5Glucagon-Like Peptide-1 Receptor Agonists, Obstructive Sleep Apnea, and Mortality in Patients with Type 2 Diabetes: the First 10 Years
    Diana Song, Yitzchak Zolty, Donald Bliwise, Cosmo Fowler
    2026SLEEP(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 563 篇论文

    合作机构(100)

    埃默里大学合作论文 52
    戈伊苏埃塔商学院合作论文 11
    斯坦福大学合作论文 11
    加州大学合作论文 10
    北卡罗来纳大学系统合作论文 9
    德克萨斯大学奥斯汀分校合作论文 8
    乔治亚州立大学合作论文 8
    耶鲁大学合作论文 7
    Georgia Institute of Technology,University System of Georgia合作论文 7
    埃默里大学医学院合作论文 7

    机构统计